Marion Pillwein
About Marion Pillwein
Marion Pillwein is the Director of R&D Quality Risk Management at Bristol Myers Squibb, with extensive experience in quality assurance and good clinical practice across the pharmaceutical and biotechnology sectors.
Current Role at Bristol Myers Squibb
Marion Pillwein currently serves as the Director of R&D Quality Risk Management at Bristol Myers Squibb, located in Boudry, Neuenburg, Schweiz. In this vital role, she oversees quality risk management processes within the research and development division, ensuring the identification, assessment, and mitigation of risks associated with clinical trials and pharmaceutical developments. Her extensive background in quality assurance and good clinical practice informs her leadership in this area.
Professional Experience at Merck Serono
Marion held multiple significant roles at Merck Serono over several years. From 2017 to 2022, she was the R&D Quality Risk Management Lead, operating from a home-based office in Austria. Prior to that, she served as the Associate Director of Quality Management from 2014 to 2016 based in Darmstadt and surrounding areas of Germany. During her tenure, she was responsible for leading quality management initiatives and implementing effective risk management strategies in the R&D domain.
Consultancy and Early Career Roles
From 2012 to 2014, Marion was a GCP QA Consultant at Selbständig, working in Zwischenwasser, Austria. In a concurrent role, she also served as a QA Consultant for Imclone Systems International from 2012 to 2013 in Heidelberg, Germany. Earlier in her career, Marion was a GCP QA Manager at Nycomed for nine years, from 2002 to 2011, in Konstanz, Germany. She also worked as a QA Manager at Altana Pharma from 2002 to 2007. These roles underline her extensive experience in various quality assurance functions across the pharmaceutical sector.
Educational Background and Microbiology Expertise
Marion Pillwein has a strong academic background in microbiology and biochemistry, which underpins her expertise in quality risk management in the pharmaceutical industry. She earned her Doctor of Philosophy (PhD) in Microbiology from the University of Veterinary Medicine Vienna, where she studied from 1996 to 2001. Additionally, she holds a Diploma in Microbiology and Biochemistry from the University of Vienna, completed from 1990 to 1996. Her in-depth scientific knowledge supports her work in ensuring the quality and safety of pharmaceutical products.
Experience in Quality Assurance and Good Clinical Practice
With over two decades of experience in quality assurance (QA) and Good Clinical Practice (GCP), Marion Pillwein has built a robust career in managing and improving quality standards in both the pharmaceutical and biotechnology sectors. She has held various leadership positions, demonstrating a proven ability to oversee quality assurance processes effectively. Her transitions from consultancy roles to permanent leadership positions highlight her adaptability and expertise in the field.